Jonathan Hundley, MD
Transplant Surgery · Atlanta, GANPI 1437168176
Payments from drug & device makers
What this record shows
18 manufacturers reported payments, led by Transmedics, Inc. at 57.6% of the total. Reporting peaked in 2024 at $2,600 and has fallen 78.7% since, to $554 in 2025.
Across 45 payments — averaging $82.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Transmedics, Inc.$2K
- Organox Ltd$597
- Boston Scientific$298
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$163
- Intercept Pharmaceuticals, Inc.$100
- AstraZeneca$79
- plus $336 from 12 others
What the payments were for
- Travel & lodging$2,13258%
- Food & beverage$1,57142%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Transmedics, Inc. | 2 | $2,132 |
| Organox Ltd | 6 | $597 |
| Boston Scientific | 2 | $298 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $163 |
| Intercept Pharmaceuticals, Inc. | 5 | $100 |
| AstraZeneca | 4 | $79 |
| Mallinckrodt Hospital Products Inc. | 3 | $69 |
| Ipsen Biopharmaceuticals, Inc | 3 | $58 |
| Sirtex Medical Inc | 2 | $46 |
| Conmed Corporation | 2 | $29 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Orphalan Inc | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| AbbVie | 1 | $19 |
| Trisalus Life Sciences, Inc. | 1 | $17 |
| Vifor Pharma, Inc. | 1 | $15 |
| Hydrofera LLC | 1 | $15 |
| Lemaitre Vascular, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,704 in reported general payments places this provider in the 60th percentile of 29 transplant surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in Atlanta
- Nicole TurgeonAtlanta$130K
- Stuart KnechtleAtlanta$88K
- Allan KirkAtlanta$80K
- Andrew AdamsAtlanta$60K
- Evan WeitmanAtlanta$40K
- Clark KensingerAtlanta$35K
- Juliano RiellaAtlanta$15K
- Harrison PollingerAtlanta$9K
- Marty SellersAtlanta$4K
- Steven KimAtlanta$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.